stanford school of medicine logostanford medicine wards

Cardiology

 

Endocrinology

 

Gastroenterology

 

General Inpatient Medicine

 

Hematology

 

Infectious Disease

 

Nephrology

 

Neurology

 

Oncology

 

Outpatient & Preventative Medicine

 

Palliative Care

 

Pulmonary/Critical Care

 

Psychiatry

 

Rheumatology

Causes of Anemia/Autoimmune Hemolytic Anemia

I. Review Broad Classification Schemes for Anemia
Two ways to think about anemia, Destruction/Blood Loss vs Underproduction


A.  Destruction/Blood Loss
1.  Blood Loss - bleeding (GIB, menstruation, trauma, etc).
2.  Hemolysis
a)  Intrinsic Causes – something structurally wrong with the RBC or hemoglobin, that predisposes to hemolysis

  • Glucose-6-phosphate dehydrogenase
  • Sickle Cell Anemia
  • Thalassemias
  • Hereditary Spherocytosis
  • Paroxysmal Nocturnal Hemogloburia

b)  Extrinsic Causes

  • Autoimmune Hemolytic Anemia
  • Infections – Malaria, Babesiosis
  • Microangiopathic Hemolytic Anemias – DIC, TTP-HUS
  • Hypersplenism
  • Traumatic (e.g. shearing from mechanical valve)

 

B.  Underproduction
Here, the morphological approach based on MCV is helpful, although many of these overlap with things in the increased destruction category
1.  Microcytic (MCV < 80) = TICS (Thalassemias, Iron Deficiency, Chronic Disease, Sideroblastic  Anemia)

2.  Macrocytic (MCV >100) - I love my mnemonic HALF MD (which I made up when was I was half of an MD in 3rd year of medical school).

  • Hypothyroidism
  • Alcoholism
  • Liver disease
  • Folate/B12 deficiency – Megaloblastic anemia
  • Myelodysplastic Syndrome
  • Drugs – e.g. AZT and other drugs that interfere with folate metabolism (5-FU, Methotrexate)
  • Unfortunately, this mnemonic does not include Reticulocytosis which is a very common cause of macrocytosis (since reticulocytes are bigger than mature RBCs).

3.  Normocytic (MCV 80-100) – Anemia of Chronic Disease and basically everything else

 

 

II.  Overview of Autoimmune Hemolytic Anemia
AIHA refers to acquired, antbody-mediated RBC destruction.
A.  Warm Antibody AIHA:

  • Mechanism - Abs opsonize RBCs at body temperature, and RBCs are removed by the reticuloendothelial system (mainly the spleen). 
  • Often idiopathic, but can be due to: viral infections, autoimmune diseases (SLE), malignancies of immune system (CLL etc), prior HSCT, and drugs (cephalosporins, PCN, NSAIDs, quinine derivatives)
  •  See spherocytes on smear (due to RBC membrane deformity)
  • Potive direct coombs for IgG +/- C3
  • Can be associated with venous thromboembolism
  • Treatment: Initial treatment with corticosteroids, if poorly responsive or resistant disease, consider elective splenectomy.  For patients unwilling or unable to undergo splenectomy, or for those who have failed or relapsed following splenectomy, consider other immunosuppressive or cytotoxic agents (ie. rituximab, azathioprine, cyclophosphamide, cyclosporine). There is insufficienct information from RCTs to choose one of these agents over another.

B.  Cold Antibody AIHA:

  •  Mechanism: IgM's that agglutinate at cold temperatures (<37 degrees), which leads to complement fixation and intravascular hemolysis (as opposed to warm Ab AIHA where RBCs are removed by the spleen).
  •  See anti C3-d on direct coombs
  • Often associated with malignancy (CLL, lymphoma, etc) or infection (mycoplasma, mononucleosis)
  • Treatment is usually directed at the underlying cause (ie. infection) and avoidance of cold triggers.  In contrast to warm ab AIHA, steroids are generally ineffective, and more commonly hematologists will jump to other immunosuppressants like Rituximab

(Chanu Rhee MD, 5/16/11)